Establishing the Glycaemic Index of Fruit Drinks Using Different Measurement Methodologies
Launched by UNIVERSITY OF BATH · Mar 20, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different fruit drinks affect blood sugar levels, which is known as the glycaemic response. Researchers want to understand how the type of fruit and the sugars in these drinks can change the way our bodies respond to them. Participants will taste eight different drinks, including five types of fruit juices, and their blood sugar levels will be measured using a fingerstick test and a continuous glucose monitor. This will help determine how each drink compares to a standard glucose drink.
To join the study, participants need to be between 18 and 65 years old, with a healthy body weight. However, people with diabetes, certain health conditions, or those who are pregnant or breastfeeding cannot participate. Those who take part will help researchers learn more about how different fruit drinks can affect blood sugar, which could provide valuable information for future dietary recommendations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: 18-65 years
- • Body mass index 18-30 kg/m2
- Exclusion Criteria:
- • diagnosis of any form of diabetes
- • intolerances or allergies to any of the study procedures (e.g. fructose/inulin intolerance)
- • Fructose malabsorption
- • Inborn errors of fructose metabolism (e.g. fructokinase deficiency, aldolase B deficiency, fructose-1,6-bisphosphatase deficiency)
- • pregnant or lactating
- • any condition that could introduce bias to the study (e.g. diagnoses of lipid disorders, including cardiovascular disease, or therapies that alter lipid or glucose metabolism, such as statins or niacin).
About University Of Bath
The University of Bath is a leading UK institution recognized for its commitment to academic excellence and innovative research. With a strong focus on health and well-being, the university conducts clinical trials that aim to advance medical knowledge and improve patient outcomes. Leveraging a multidisciplinary approach, the University of Bath collaborates with various stakeholders, including healthcare professionals and industry partners, to ensure the integrity and efficacy of its research initiatives. Through its state-of-the-art facilities and expertise, the university is dedicated to contributing valuable insights to the scientific community and enhancing the quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bath, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported